Genomic and Precision Medicine Volume 7: Neurological Diseases

Genomic and Precision Medicine: Neurological Diseases discusses the applications of genome discovery on the broad spectrum of pernicious conditions in this area - movement disorders, autism, epilepsy and depression included.  Each chapter will be organized to cover the application of genomics and personalized medicine tools and technologies to a) Risk Assessment and Susceptibility, b) Diagnosis and Prognosis, c) Pharmacogenomics and Precision Therapeutics, and d) Emerging and Future Opportunities in the field.

• A comprehensive volume written and edited by neurological genomic specialists for neurological health care providers
• Succinct commentary and key learning points that will assist providers with their local needs for implementation of genomic and personalized medicine into practice
• An up to date overview on major opportunities today for genomic and personalized medicine in practice
• Case studies highlight the practical use of genomics in the management in patients

Dr. Ginsburg is the founding Director of the Center for Applied Genomics & Precision Medicine in the Duke Institute for Genome Sciences & Policy. He is also Professor of Medicine and of Pathology at Duke University Medical Center, Professor of Biomedical Engineering at Duke Pratt School of Engineering, and Co-Director of the Duke Translational Medicine Institute.
Huntington Willard is on the faculty of the Department of Human Genetics at the University of Chicago. Prior to this appointment, Willard was the President and Director of the Marine Biological Laboratory and Professor of Human Genetics at the University of Chicago. He was previously on the faculty at Duke University, where he was founding director of the university-wide Duke Institute for Genome Sciences & Policy from 2003 to 2014, the Nanaline H. Duke Professor of Genome Sciences, and the Arts & Sciences Professor of Biology & Genome Sciences.